Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2369
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1 ; volume:17 ; number:1 ; day:5 ; month:4 ; year:2016 ; pages:1-11 ; date:12.2016
BMC nephrology ; 17, Heft 1 (5.4.2016), 1-11, 12.2016
- Urheber
-
Ebefors, Kerstin
- Beteiligte Personen und Organisationen
-
Liu, Peidi
Lassén, Emelie
Elvin, Johannes
Candemark, Emma
Levan, Kristina
Haraldsson, Börje
Nyström, Jenny
SpringerLink (Online service)
- DOI
-
10.1186/s12882-016-0251-5
- URN
-
urn:nbn:de:1111-201604066811
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ebefors, Kerstin
- Liu, Peidi
- Lassén, Emelie
- Elvin, Johannes
- Candemark, Emma
- Levan, Kristina
- Haraldsson, Börje
- Nyström, Jenny
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
Glomerular spatial transcriptomics of IgA nephropathy according to the presence of mesangial proliferation
Relationship between IgM deposition in the mesangial region and the prognosis of IgA nephropathy: a single-centre retrospective study
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
Glomerular spatial transcriptomics of IgA nephropathy according to the presence of mesangial proliferation
Relationship between IgM deposition in the mesangial region and the prognosis of IgA nephropathy: a single-centre retrospective study
Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy
Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report
Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis
Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
Comprehensive analysis of aberrantly expressed profiles of mRNA and its relationship with serum galactose-deficient IgA1 level in IgA nephropathy
Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
Glomerular spatial transcriptomics of IgA nephropathy according to the presence of mesangial proliferation